Nextage Therapeutics (Israel) Today
| NXTG Stock | ILA 67.70 1.70 2.45% |
Performance2 of 100
| Odds Of DistressLess than 32
|
Nextage Therapeutics is trading at 67.70 as of the 2nd of December 2024, a 2.45 percent decrease since the beginning of the trading day. The stock's open price was 69.4. Nextage Therapeutics has about a 32 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Nextage Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of December 2022 and ending today, the 2nd of December 2024. Click here to learn more.
Nextage Therapeutics Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. The company was formerly known as Micromedic Technologies Ltd and changed its name to Nextage Therapeutics Ltd in August 2020. NEXTAGE THERAPEUTI operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange.. The company has 26.14 M outstanding shares. More on Nextage Therapeutics
Moving together with Nextage Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nextage Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nextage Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nextage Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Nextage Therapeutics (NXTG) is traded on Tel Aviv Stock Exchange in Israel and employs 65 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nextage Therapeutics's market, we take the total number of its shares issued and multiply it by Nextage Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nextage Therapeutics operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 26.14 M outstanding shares.
Nextage Therapeutics has accumulated about 358 K in cash with (3.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check Nextage Therapeutics Probability Of Bankruptcy
Ownership AllocationNextage Therapeutics maintains a total of 26.14 Million outstanding shares. Nextage Therapeutics secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.36 % of Nextage Therapeutics outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nextage Ownership Details
Nextage Therapeutics Risk Profiles
Although Nextage Therapeutics' alpha and beta are two of the key measurements used to evaluate Nextage Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.8 | |||
| Semi Deviation | 3.93 | |||
| Standard Deviation | 5.94 | |||
| Variance | 35.26 |
Nextage Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nextage Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Other Information on Investing in Nextage Stock
Nextage Therapeutics financial ratios help investors to determine whether Nextage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nextage with respect to the benefits of owning Nextage Therapeutics security.